
Merck & Co and Moderna Proceed with Cancer Vaccine
US drugmaker Merck & Co is going ahead with plans to develop a therapeutic cancer vaccine called mRNA-4157 together with Covid vaccine maker Moderna. This fulfills an agreement first signed in 2016 and amended in 2018.